{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:18:43Z","timestamp":1790245123300,"version":"4.1.0"},"reference-count":11,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1553,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1177\/0091270010375427","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T02:20:30Z","timestamp":1280283630000},"page":"842-856","source":"Crossref","is-referenced-by-count":76,"title":["Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura"],"prefix":"10.1002","volume":"51","author":[{"given":"Ekaterina","family":"Gibiansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"10.1177\/0091270010375427-BIB1|cit1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1177\/0091270010375427-BIB2|cit2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1359-6101(01)00030-2","article-title":"Thrombopoietin: a pan-hematopoietic cytokine","volume":"13","author":"Geddis","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1177\/0091270010375427-BIB3|cit3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/blood.V100.2.728","article-title":"Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura","volume":"100","author":"Nomura","year":"2002","journal-title":"Blood"},{"key":"10.1177\/0091270010375427-BIB4|cit4","first-page":"86a","article-title":"An open-label, dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG 531) in thrombocytopenic adult patients with immune thrombocytopenic purpura (ITP)","volume":"102","author":"Bussel","year":"2003","journal-title":"Blood"},{"key":"10.1177\/0091270010375427-BIB5|cit5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","article-title":"Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies","volume":"76","author":"Aledort","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1177\/0091270010375427-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1177\/0091270010375427-BIB7|cit7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"key":"10.1177\/0091270010375427-BIB8|cit8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2009.04.010","article-title":"Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adults: two single-dose, open-label, randomized-sequence, crossover studies","volume":"31","author":"Williams","year":"2009","journal-title":"Clin Ther"},{"key":"10.1177\/0091270010375427-BIB9|cit9","unstructured":"Beal SL Sheiner LB Boeckmann AJ NONMEM Users Guides (1989-2006) Icon Development Solutions"},{"key":"10.1177\/0091270010375427-BIB10|cit10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-200241010-00006","article-title":"Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants","volume":"41","author":"Leger","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1177\/0091270010375427-BIB11|cit11","volume-title":"NONMEM Users Guide-Introduction to Version VI","year":"2008"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270010375427","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1177\/0091270010375427\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T12:56:35Z","timestamp":1657803395000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1177\/0091270010375427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1177\/0091270010375427","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}